Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution1 total trials
Phase 4Post-market surveillance
1(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Recruiting1
Not yet recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (100.0%)

Trials by Status

recruiting133%
not_yet_recruiting133%
completed133%

Recent Activity

1 active trials
Showing 3 of 3
recruiting

Metabolomics of Cancers of the Upper Aerodigestive Tract

NCT07377084
not_yet_recruiting

Detection of Circulating Therapeutic Monoclonal Antibodies in Biological Samples of Gynecological Cancer Patients.

NCT06797479
completedphase_4

Study Of Bioavailability Of Two Sildenafil 100mg Oral Tablet Formulations

NCT00902512

Clinical Trials (3)

Showing 3 of 3 trials
NCT07377084

Metabolomics of Cancers of the Upper Aerodigestive Tract

Recruiting
NCT06797479

Detection of Circulating Therapeutic Monoclonal Antibodies in Biological Samples of Gynecological Cancer Patients.

Not Yet Recruiting
NCT00902512Phase 4

Study Of Bioavailability Of Two Sildenafil 100mg Oral Tablet Formulations

Completed

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3